The prognostic significance of the half-lives (HLs) of α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) in patients undergoing hepatectomy for hepatocellular carcinoma (HCC) is unclear. We evaluated the HLs of AFP and DCP in a cohort of such patients.
INTRODUCTION
H EPATOCELLULAR CARCINOMA (HCC) is a common malignancy worldwide. 1 Hepatectomy achieves favorable outcomes in well-selected candidates and is considered a potentially curative treatment for HCC. 2 Unfortunately, long-term survival after hepatectomy is unsatisfactory because of the high incidence of tumor recurrence, especially intrahepatic recurrence. 3 After curative resection of HCC, the recurrence rates at 2 and 5 years are approximately 50-60% and 80%, respectively. [4] [5] [6] In Japan, two tumor markers are used clinically to assess patients with HCC; α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP). Increases in tumor markers are useful in diagnosing this malignancy or its recurrence after curative treatment. [7] [8] [9] There is a poor correlation between AFP and DCP concentrations; additionally, different tumor characteristics are associated with DCP than with AFP. Measurement of both AFP and DCP concentrations therefore increases the sensitivity of diagnosis and evaluation of tumor characteristics. We have previously reported that preoperative AFP and DCP doubling times are useful for predicting early recurrence and post-hepatectomy prognosis in patients with HCC. 10 Post-treatment changes in these tumor markers assist in evaluating tumor activity; points may predict post-treatment prognosis. Recently, Shim et al. reported that AFP half-life (HL) reflects prognosis after liver resection for HCC. 12 However, these authors only assessed patients with AFP concentrations exceeding 100 ng/mL; these patients comprised only approximately 35% of their total HCC cohort. Thus, assessing changes in both AFP and DCP concentrations over time could enable development of a prognostic risk model that is applicable to a greater proportion of patients with HCC. Nevertheless, there are few reports regarding the associations between changes in DCP concentrations and prognosis. Therefore, we studied the clinical significance of the post-hepatectomy HLs of tumor markers DCP and AFP in patients with HCC and high concentrations of either or both of these tumor markers.
METHODS

Patients
B
ETWEEN JANUARY 2005 and August 2011, 740 patients underwent curative hepatectomy for HCC in the Department of Gastroenterological Surgery, Kumamoto University Hospital (Kumamoto, Japan). They underwent imaging studies, including ultrasound, dynamic computed tomography (CT), enhanced magnetic resonance imaging, and CT angiography for diagnosis and staging of their HCCs preoperatively. The criteria for hepatectomy were based on the results of preoperative radiological imaging and hepatic functional reserve. The required hepatic functional reserve to undertake hepatectomy and safe extent of hepatectomy were assessed by the indocyanine green (ICG) clearance test and functional  remnant liver volume assessed by   99m Tc-GSA scintigraphy. [13] [14] [15] Patients with tumor marker concentrations more than five times the upper limit of normal (20 ng/mL for AFP; 40 mAU/mL for DCP in our institution), that is, preoperative AFP concentration >100 ng/mL or DCP >200 mAU/mL within the week before hepatectomy, were included in this study. Exclusion criteria were as follows: (i) receiving warfarin; (ii) undergoing radiofrequency ablation (RFA) during hepatectomy; and (iii) tumor markers not measured 1 month after hepatectomy. Data of the remaining 202 patients were analyzed (Fig. 1) . All patients were diagnosed as having HCC without positive tumor margins by pathological examination of the resected specimens. The AFP cohort was defined as patients with preoperative AFP >100 ng/mL (n = 116) and the DCP cohort as patients with preoperative DCP >200 mAU/mL (n = 138). The values of AFP and DCP exceeded 100 ng/mL and 200 mAU/mL, respectively, in 52 patients (Fig. 1) . All clinicopathological and prognostic data were collected prospectively. This study was carried out in accordance with the principles of the Declaration of Helsinki and the ethical guidelines for clinical studies of the Figure 1 Flow diagram of this study of the clinical significance of half-lives of tumor markers α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) after hepatectomy for hepatocellular carcinoma (HCC). RFA, radiofrequency ablation.
Ministry of Health, Labor and Welfare of Japan. Written informed consent for participation was obtained from all patients.
Measurement of tumor marker concentrations and calculation of HLs
Both AFP and DCP were measured in all patients with HCC 1 week before hepatectomy. Serum AFP and DCP concentrations were measured using chemiluminescent enzyme immunoassays (AFP: Siemens Immulite AFP IV; Mitsubishi Chemical Medience, Tokyo, Japan; and DCP: Lumipulse PIVKA-II Eisai; Eisai, Tokyo, Japan). In our institution, the upper limits for AFP and DCP serum concentrations are 20 ng/mL and 40 mAU/mL, respectively. Serum AFP and DCP HLs were calculated by using the following exponential and logarithmic formula, as previously described:
12,16,17 HL = 0.3 × ΔT/log 10 (C0/C1) where ΔT is the time (days) between C0 and C1, C0 is the baseline marker concentration, and C1 the concentration after ΔT postoperative days. C0 was obtained less than 1 week before hepatectomy; C1 was obtained 1 month after hepatectomy. This formula is based on an exponential decay process:
, where N(t) is the amount at time t, N0 the initial amount, and t1/2 the HL of the substance measured. 18 
Classification of patient groups according to tumor marker HLs
Tumor markers that were within the normal range (AFP <20 ng/mL or DCP <40 mAU/mL) 1 month after hepatectomy were defined as AFP-normalization or DCP-normalization; the HLs could not be assessed in patients in these cases. Cut-off values for HLs were defined as proposed in previous reports as follows: AFP HLs of <7 days or ≥7 days were defined as short or long AFP, respectively, and DCP HLs of <4 days or ≥4 days were defined as short or long DCP, respectively. 12, 19 Increases at 1 month after hepatectomy over preoperative values of AFP or DCP concentrations were classified as long AFP (n = 3) or long DCP (n = 2), respectively.
In the whole cohort (n = 202), a normalization group was defined as patients with both AFP and DCP within the normal range 1 month after hepatectomy. The long group was defined as patients with either long AFP or DCP, or both. The short group was defined as all patients not in the normalization or long groups.
Follow-up
Liver protocol enhanced CT scans covering most of the chest were examined routinely in all postoperative HCC patients 1 month after hepatectomy, as were serum concentrations of the two specified tumor markers, AFP and DCP. These investigations were generally repeated thereafter approximately every 3 months in the first 2 years and every 3-6 months in subsequent years until tumor recurrence. Recurrence was diagnosed based on the findings of two or more different imaging techniques, including magnetic resonance imaging. Recurrences were resected when possible; transcatheter arterial chemoembolization, RFA, or systemic chemotherapy was administered to patients with unresectable recurrences.
Data collection
Information on clinicopathological variables suspected as risk factors for recurrence and survival was collected for each patient. In addition, the continuous variables of age, tumor size, serum albumin, prothrombin time, ICG retention rate at 15 min (ICG-R15), preoperative AFP and DCP concentrations, duration of surgery, and amount of bleeding were categorized by their median cut-off values. Gross vascular invasion diagnosed on preoperative images and microvascular invasion diagnosed by pathological findings were defined as vascular invasion. Hepatocellular carcinomas were defined as poorly differentiated if they contained poorly differentiated components on pathological examination. Major hepatectomy was defined as resection of three or more liver segments.
Statistical analyses
JMP (version 12; SAS Institute, Cary, NC, USA) was used for the statistical analyses. The χ 2 -test or Fisher's exact test was used where appropriate to compare clinical and histological variables between the two groups. Cumulative survival curves were constructed using the Kaplan-Meier method. Survival curves were statistically compared using the log-rank test. Data from all cases were subjected to univariate analysis. Variables with a P-value <0.05 on univariate analysis were subjected to multivariate analysis using the Cox proportional hazards model. For all tests, the level of significance was set at P < 0.05.
RESULTS
Classification according to concentrations and HLs of tumor markers
I N THE AFP cohort, the 3-year recurrence-free survival (RFS) of patients in the normalization (n = 16), short AFP (n = 62), and long AFP (n = 38) groups were 57.4%, 49.3%, and 11.7%, respectively (P = 0.02) (Fig. 2a) and the 5 years OS were 92.3%, 69.3%, and 46.4%, respectively (P = 0.02) (Fig. 2b ).
In the DCP cohort, the 3-year RFS of the patients in the normalization (n = 84), short DCP (n = 27), and long DCP (n = 27) groups was 40.9%, 13.3%, and 15.7%, respectively (P = 0.0007) (Fig. 2c ) and the 5-year OS was 66.4%, 57.8%, and 39.9%, respectively (P = 0.04) (Fig. 2d) .
The relationships between HL and survival time after hepatectomy are shown in Figure S1 . R 2 for the relationship between recurrence-free time and AFP HL and DCP HL were both 0.01 (Fig. S1a,c) . R 2 between survival time and AFP-HL and DCP-HL were 0.04 and 0.06, respectively (Fig. S1b,d ). There were no significant relationships between recurrence-free and survival time and HLs.
Comparison of patients' characteristics according to HL in the whole cohort (n = 202)
Characteristics of all patients according to HLs of tumor markers are shown in Table 1 . There were significant differences between the three groups in terms of sex, tumor size, platelet count, prothrombin time, ICG-R15, preoperative AFP concentration, Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) value, major hepatectomy, and Figure 2 Recurrence-free survival (RFS) and overall survival (OS) of patients with hepatocellular carcinoma undergoing hepatectomy according to half-lives of α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP). (a) Among the AFP cohort, the 3-year RFS of patients in the normalization (n = 16), short (n = 62), and long groups (n = 38) was 57.4%, 49.3%, and 11.7%, respectively (P = 0.02). (b) Among the AFP cohort, the 5-year OS of patients in the normalization (n = 16), short (n = 62), and long groups (n = 38) was 92.3%, 69.3%, and 46.4%, respectively (P = 0.02). (c) Among the DCP cohort, the 3-year RFS of patients in the normalization (n = 84), short (n = 27), and long groups (n = 27) was 40.9%, 13.3%, and 15.7%, respectively (P = 0.0007). (d) Among the DCP cohort, the 5-year OS of patients in the normalization, short, and long groups was 66.4%, 57.8%, and 39.9%, respectively (P = 0.04). Black line, long group; dotted line, short group; gray line, normalization group. rate of poorly differentiated tumors. There were no significant differences between the groups in tumor number, intraoperative factors, or complications.
Associations between HL and prognosis in the whole cohort Kaplan-Meier curves for RFS and OS are shown in Figure 3 . The median duration of follow-up was 39.2 months (95% confidence interval [CI], 35.9-48.1). In the whole cohort, 59 patients died of recurrence or progression of HCC during follow-up. The 3-year RFS was 41.3% in the normalization group, 46.0% in the short group, and 16.8% in the long group; these differences are significant (P = 0.002) (Fig. 3a) . The 5-year OS in the normalization, short, and long groups were 72.6%, 70.6%, and 43.8%, respectively; these differences are significant (P = 0.002) (Fig. 3b) . However, there were no significant differences between the normalization and short groups in terms of either RFS (P = 0.92) or OS (P = 0.40).
Risk factors for survival and recurrence in whole cohort
Next, the risk factors for poor prognosis were evaluated. According to univariate analysis, male sex, tumor diameter (-45 mm), serum albumin (<3.9 g/dL), operation time (≥413 min), bleeding (≥410 g), transfusion, vascular invasion, preoperative DCP concentration (≥238 ng/mL), and long HL were risk factors for poor RFS (Table 2) . Multivariate analysis identified male sex (hazard ratio [HR] 1.76; 95% CI, 1.12-2.90; P = 0.01), transfusion (HR 1.82; 95% CI, 1.09-2.97; P = 0.02), vascular invasion (HR 1.90; 95% CI, 1.22-2.99; P = 0.004), and long HL (HR 2.21; 95% CI, 1.41-3.49; P = 0.0006) as risk factors for poor RFS (Table 2 ). Univariate analysis revealed that tumor diameter (≥45 mm), serum albumin (<3.9 g/dL), operation time (≥413 min), bleeding (≥410 g), transfusion, fibrosis, vascular invasion, preoperative DCP concentration (≥688 mAU/mL), AFP-L3 (≥10%), and HL were risk factors for poor OS (Table 3 ). Multivariate analysis identified that tumor diameter (HR 2.18; 95% CI, 1.12-4.34; P = 0.02), 20 Data are shown as mean ± standard error or n (%).
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transfusion (HR 1.99; 95% CI, 1.02-3.80; P = 0.04), fibrosis stage 3-4 (HR 2.16; 95% CI, 1.20-3.93; P = 0.01), and long HL (HR 2.70; 95% CI, 1.37-5.47; P = 0.004) were independent risk factors for poor OS (Table 3) .
Pattern of recurrence of HCC according to HL
During follow-up, 119 patients had HCC recurrence, initial recurrence sites being intrahepatic (n = 99), lung (n = 17), bone (n = 4), lymph node (n = 3), brain (n = 2), adrenal gland (n = 1), and inferior vena cava (n = 1). In the long group, 21.3% (13/61) of initial recurrences were extrahepatic, which is a significantly higher percentage than in the normalization group (6.0%, 6/70) (P = 0.04) (Fig. 4) and marginally higher than in the short group (9.9%, 7/71) (P = 0.07).
DISCUSSION
H IGH SERUM CONCENTRATIONS of tumor markers are useful both for predicting malignancy and diagnosing recurrence of HCC after treatment. 8, 9 Changes in these concentrations are essential for early detection of recurrence, especially in patients who had high values preoperatively and underwent curative treatment. In this study, we showed that long HLs of AFP or DCP are the most significant predictors of both RFS and OS in patients with initial AFP concentrations exceeding 100 ng/mL or DCP exceeding 200 mAU/mL (Tables 2, 3 ). In other words, among patients with preoperative tumor marker concentrations of more than fivefold the upper limit of normal, HL of AFP longer than 7 days or DCP longer than 4 days was the strongest predictor of poor prognosis. In contrast, preoperative tumor marker concentrations do not always reflect prognosis after curative hepatectomy. 21, 22 In our study, neither preoperative AFP nor DCP were risk factors for OS or RFS according to multivariate analysis (Tables 2, 3) . A single measurement of tumor marker concentration is inadequate for predicting survival or stratifying risk of postoperative recurrence. Tumor marker concentrations must be measured at least before and after hepatectomy to calculate their HLs, which are useful prognostic indicators in patients with high preoperative AFP or DCP concentrations, or both.
During follow-up, 155 patients (77%) eventually achieved tumor marker normalization whereas 47 patients (23%) did not. There were 19 (27%) and 28 (46%) patients who never achieved normalization in the short and long groups, respectively. The rate of failure to achieve normalization was significantly higher in the long than in the short group (P = 0.02). Because 36 patients of the 47 patients (77%) who failed to achieve normalization developed recurrence, failure to achieve normalization during follow-up was almost directly associated with recurrence and death caused by cancer. However, long follow-up is Figure 3 Recurrence-free survival (RFS) and overall survival (OS) of patients with hepatocellular carcinoma undergoing hepatectomy according to half-lives of tumor markers. (a) The 3-year RFS rates were 41.3% in the normalization, 46.0% in the short, and 16.8% in the long group; these differences are significant (P = 0.002). (b) The 5-year OS in the normalization, short, and long groups (5 years after hepatectomy) was 72.6%, 70.6%, and 43.8%, respectively; these differences are significant (P = 0.002). However, there were no significant differences between the normalization and short groups in either RFS (P = 0.92) or OS (P = 0.40). Black line, long group; dotted line, short group; gray line, normalization group. required to determine whether final normalization eventually occurs. It is therefore important to develop a means of predicting in the early postoperative period whether normalization will be achieved. We determined the statistical power by using receiver operating characteristic (ROC) curve analysis. The C-index for HL classification (normalization, short, and long) predicting normalization was 0.800 by ROC analysis, which is higher than for the other variables investigated (Table S1) . Therefore, long HL may be a good predictor of both prognosis and failure to 0.0006 †Log-rank test. ‡Cox proportional hazards.AFP, α-fetoprotein; AFP-L3, Lens culinaris agglutinin-reactive fraction of AFP; CI, confidence interval; DCP, des-γ-carboxy prothrombin; HR, hazard ratio; ICG-R15, indocyanine green retention rate at 15 min.
§Values are median. ¶Extent of liver fibrosis (F stage) was classified according to the new Inuyama classification system. achieve normalization, which would indicate that a long HL reflects the presence of unrecognized residual tumor. Recently, Okamura et al. reported that DCP HL may be an independent prognostic factor. 19 One limitation of measuring either AFP HL or DCP HL is the small proportion of patients in whom either one is applicable: in our study, only 15.7% (116/740) or 18.6% (138/740) of patients had initial AFP concentrations exceeding 100 ng/mL or DCP concentrations exceeding 200mAU/ml, respectively. However, adding the AFP and DCP cohorts together enabled the use of HLs in 27.3% (202/740) of all patients with HCC. Thus, using HLs of both AFP and DCP is more useful in clinical practice. Recurrence and prognosis can be partially predicted based on information about histopathological findings and postoperative course 1 month after hepatectomy. Pathological findings such as microvascular invasion, poor tumor differentiation, and postoperative complications are reportedly possible risk factors for poor prognosis. [23] [24] [25] [26] [27] However, in this study, long HL was a stronger risk factor for OS and RFS than pathological finding or postoperative complications according to multivariate analysis (Tables 2, 3 ). Thus, HLs of tumor markers are novel and reliable prognostic indicators after hepatectomy for HCC.
In this study, prognosis and extrahepatic recurrence rate were equivalent in the normalization and short groups. Therefore, even when tumor marker concentrations do not return to within the normal range 1 month after hepatectomy, a short HL may indicate a favorable prognosis. Conversely, long HL was associated with poor prognosis and extrahepatic recurrence, even after pathologically curative resection. Murata et al. reported that hypoxic stimulation induces DCP production by HCC cell lines and epithelial-mesenchymal transition (EMT). 28 Post-hepatectomy remnant livers tend to be hypoxic 29 and hypoxic changes in remnant liver may induce unrecognized residual cancer cells to produce DCP and EMT, resulting in prolongation of the decline in DCP concentrations and extrahepatic metastasis. The high rates of extrahepatic metastasis as initial recurrence indicate that pathologically curative resections may not be biologically curative. Therefore, patients with long HLs should be followed up carefully with whole-body CT scans to detect early extrahepatic recurrence. Moreover, adjuvant therapy such as hepatic arterial infusion or systemic chemotherapy may be indicated to control residual undetectable cancer cells. 3, 30 This study had some limitations. First, although it is well accepted that the HL of DCP is approximately 2-3 days, shorter than that of AFP (4-6 days), 31, 32 we used the same formula to calculate HLs of DCP and AFP, using concentrations before and 1 month after surgery. When we calculated the HL of DCP using the concentration 7 days after surgery, we found no significant differences between the normalization, short, or long groups in OS and RFS. Thus, our data indicate that it is preferable to evaluate HL using the DCP concentration between 1 week and 1 month after surgery for predicting prognosis; however, it is traditionally not measured at this stage. Second, high AFP and DCP concentrations may reflect not only tumor factors but also fibrosis of the background liver. [33] [34] [35] Table 1 shows that indicators of preoperative liver function, such as platelet count, prothrombin time, and ICG-R15, differed significantly between the three groups, suggesting that prolongation of HLs is affected by both tumor factors and fibrosis in the background liver. Moreover, AFP concentrations are affected by hepatocyte regeneration. 35, 36 The rate of major hepatectomy was higher in the short than the normalization group. Because the amount of liver regeneration is directly related to the amount of liver parenchyma resected, 37 AFP concentration after major hepatectomy may be higher than after minor hepatectomy in the early postoperative period. Therefore, failure to achieve AFP normalization within 1 month of major hepatectomy in the short group may be attributable to disruption of postoperative AFP decreasing by liver regeneration. Further investigation is necessary to establish a tumor-specific HL.
In conclusion, long HLs (AFP ≥7 days or DCP ≥4 days) are useful prognostic markers for patients with HCC after curative hepatectomy. In particular, patients with long HLs are more likely to develop extrahepatic recurrence. Therefore, calculation of HL could be useful in individualizing treatment strategies after hepatectomy in patients with HCC. Figure 4 Rates of initial extrahepatic recurrence according to halflives of tumor markers in patients with hepatocellular carcinoma who underwent hepatectomy. The rates of initial extrahepatic recurrence in the normalization, short, and long groups were 6.0% (6/70), 9.9% (7/71), and 23.0% (14/61), respectively. The rate of initial extrahepatic recurrence was significantly higher in the long group than in the normalization (P = 0.01) and short group (P = 0.04).
